Abbott Laboratories Aktie
110,38
EUR
+0,48
EUR
+0,44
%
113,69
USD
+0,20
USD
+0,18
%
nachbörslich
Werbung
Abbott Laboratories Aktie Analyse
| 27.08.20 | Abbott Laboratories Sell | Goldman Sachs Group Inc. | |
| 16.10.18 | Abbott Laboratories overweight | Barclays Capital | |
| 25.01.18 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
| 15.12.17 | Abbott Laboratories Outperform | BMO Capital Markets | |
| 19.10.17 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
| 19.10.17 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 28.09.17 | Abbott Laboratories overweight | Barclays Capital | |
| 21.06.17 | Abbott Laboratories Buy | BTIG Research | |
|
Werbung
|
|||
| 20.04.17 | Abbott Laboratories overweight | Barclays Capital | |
| 17.03.17 | Abbott Laboratories Market Perform | BMO Capital Markets | |
| 01.03.17 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 26.01.17 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 21.07.16 | Abbott Laboratories overweight | Barclays Capital | |
| 21.06.16 | Abbott Laboratories Buy | Edward Jones | |
| 11.04.16 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 09.10.15 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 07.10.15 | Abbott Laboratories overweight | Barclays Capital | |
| 23.07.15 | Abbott Laboratories Equal weight | Barclays Capital | |
| 23.07.15 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
| 23.07.15 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 23.04.15 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
| 27.03.15 | Abbott Laboratories Equal weight | Barclays Capital | |
| 30.01.15 | Abbott Laboratories Equal weight | Barclays Capital | |
| 30.01.15 | Abbott Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
| 22.09.14 | Abbott Laboratories Outperform | RBC Capital Markets | |
| 07.01.13 | Abbott Laboratories halten | Deutsche Bank Securities | |
| 10.12.12 | Abbott Laboratories buy | UBS AG | |
| 29.11.12 | Abbott Laboratories neutral | Sarasin Research | |
| 15.11.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 07.11.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 07.11.12 | Abbott Laboratories buy | UBS AG | |
| 18.10.12 | Abbott Laboratories neutral | Sarasin Research | |
| 15.10.12 | Abbott Laboratories buy | UBS AG | |
| 15.10.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 05.10.12 | Abbott Laboratories kaufen | Fuchsbriefe | |
| 27.09.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 17.09.12 | Abbott Laboratories buy | UBS AG | |
| 06.08.12 | Abbott Laboratories kaufen | Die Actien-Börse | |
| 20.07.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 19.07.12 | Abbott Laboratories buy | UBS AG | |
| 06.06.12 | Abbott Laboratories buy | UBS AG | |
| 07.05.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 24.04.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 19.04.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 19.04.12 | Abbott Laboratories neutral | Sarasin Research | |
| 16.04.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 19.03.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 19.03.12 | Abbott Laboratories buy | UBS AG | |
| 01.03.12 | Abbott Laboratories buy | UBS AG | |
| 26.01.12 | Abbott Laboratories outperform | RBC Capital Markets | |
Werbung